Department of Pharmacy & Pharmacology

Research Output

Filter
Other contribution
Other contribution

AB0735 SEVERITY OF NAIL PSORIASIS SCORE (SNAPS) DEMONSTRATES LONGITUDINAL CONSTRUCT VALIDITY AGAINST THE MODIFIED NAIL PSORIASIS SEVERITY INDEX (mNAPSI) IN AN OBSERVATIONAL COHORT OF PATIENTS WITH PSORIATIC ARTHRITIS

Antony, A., Saeed, S., Hart, D., Nair, P., Cavill, C., Korendowych, E., Mchugh, N., Lovell, C. & Tillett, W., 1 May 2020, BMJ Publishing Group Ltd.

Research output: Other contribution

AB0756 GUSELKUMAB IMPROVED WORK PRODUCTIVITY AND DAILY ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 TRIAL

Curtis, J., Mcinnes, I., Rahman, P., Tillett, W., Mease, PJ., Kollmeier, A., Hsia, EC., Zhou, B., Agarwal, P. & Peterson, S., 1 May 2020, BMJ Publishing Group Ltd.

Research output: Other contribution

AB0811 DEMOGRAPHIC, TREATMENT AND DISEASE CHARACTERISTICS OF PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING TOFACITINIB IN THE UNITED STATES, FRANCE, GERMANY, ITALY, SPAIN AND THE UNITED KINGDOM

Ogdie, A., Schmerold, L., Tillett, W., Germino, R., Cappelleri, JC. & Young, P., 1 May 2020, BMJ Publishing Group Ltd.

Research output: Other contribution

AB0819 FLARES AMONG PATIENTS WITH PSORIATIC ARTHRITIS (PsA)-FREQUENCY AND IMPACT ON PATIENT OUTCOMES: REAL-WORLD SURVEY IN THE US AND EUROPE

Orbai, AM., Tillett, W., Grieb, S., Peterson, S., Holdsworth, E., Meakin, S., Wirta, S. B., Chakravarty, SD. & Gossec, L., 1 May 2020, BMJ Publishing Group Ltd.

Research output: Other contribution

AB0839 RELIABILITY OF COMPOSITE MEASURES FOR THE ASSESSMENT OF PSORIATIC ARTHRITIS

Tillett, W., Helliwell, P., Fitzgerald, O., Waxman, R., Antony, A., Coates, LC., Jadon, D., Creamer, P., Lane, S. & Massarotti, M., 1 May 2020, BMJ Publishing Group Ltd.

Research output: Other contribution

Dissolution testing

Moss, S. H., 2005, Commercial and Academic Services, Bath.

Research output: Other contribution

Drug misuse and dependence: UK guidelines on clinical management

Strang, P. S. J. & Independent Expert Working Group (2017) , 14 Jul 2017, 317 p. London

Research output: Other contribution

FRI0358 USAGE OF C-REACTIVE PROTEIN TESTING IN THE DIAGNOSIS AND MONITORING OF PSORIATIC ARTHRITIS (PSA): RESULTS FROM A REAL-WORLD SURVEY IN THE US AND EUROPE

Ogdie, A., Tillett, W., Eder, L., Booth, N., Wirta, S. B., Howell, O., Schubert, A., Peterson, S., Chakravarty, SD. & Coates, LC., 1 May 2020, BMJ Publishing Group Ltd.

Research output: Other contribution

File

Lipidex

Moss, S. H., 2006, Bath : Commercial and Academic Services.

Research output: Other contribution

MiDatabank

Moss, S. H., 2006, Bath : Commercial and Academic Services, Bath.

Research output: Other contribution

OP0050 ADALIMUMAB INTRODUCTION VERSUS METHOTREXATE DOSE ESCALATION IN PATIENTS WITH INADEQUATELY CONTROLLED PSORIATIC ARTHRITIS: RESULTS FROM RANDOMIZED PHASE 4 CONTROL STUDY

Coates, LC., Tillett, W., D’agostino, MA., Rahman, P., Behrens, F., Conaghan, PG., Mcdearmon-Blondell, E., Bu, X., Chen, L. & Kapoor, M., 1 May 2020, BMJ Publishing Group Ltd.

Research output: Other contribution

OP0223 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PSA-2): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL

Genovese, MC., Lertratanakul, A., Anderson, J., Papp, K., Tillett, W., Van den Bosch, F., Tsuji, S., Dokoupilova, E., Keiserman, M. & Wang, X., 1 May 2020, BMJ Publishing Group Ltd.

Research output: Other contribution

Sunlight and you

Moss, S. H., 2007, Bath University : Commercial and Academic Services, Bath.

Research output: Other contribution